Waters Corp /De/WAT
What Waters Corp /De/ does.
Waters Corporation (the “Company,” “we,” “our,” or “us”), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving life, materials and food sciences for more than 65 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (“HPLC”), ultra-performance liquid chromatography (“UPLC” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that are frequently employed together (“LC-MS”) and sold as integrated instrument systems using common software platforms.
The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS technology, principally in conjunction with chromatography, is employed in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), nutritional safety analysis and environmental testing. LC-MS instruments combine a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. In addition, the Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (“TA”) product line. These instruments are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.8B | $3.0B | $3.0B | $3.0B | $3.2B |
| Net income | $521.6M | $692.8M | $707.8M | $642.2M | $637.8M | $642.6M |
| Free cash flow | — | — | — | $442.2M | $619.6M | $539.8M |
More on WAT.
- Waters Corp /De/ summary
- Waters Corp /De/ financial statements
- Waters Corp /De/ key metrics
- Waters Corp /De/ health scores and style box
- Waters Corp /De/ earnings
- Waters Corp /De/ dividends
- Waters Corp /De/ valuation
- Waters Corp /De/ ownership and insiders
- Waters Corp /De/ peers
Figures from Waters Corp /De/'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.